• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Phillips Medisize buys mini-tablet dispenser from Global Pharmaceutical Company

September 10, 2019 By Danielle Kirsh

Phillips-Medisize today said that it acquired exclusive ownership of patents supporting a mini-tablet dispenser from Global Pharmaceutical Company.

The mini-tablet dispenser is mounted on top of a standard tablet bottle where a patient or caregiver can count and dispense mini-tablets in predetermined amounts from one to 20 tablets. It supports tablets sized 2×2 mm to 2.3×2.3 mm. The dispenser also allows users to visually confirm a measured tablet count before dispensing. It also reduces damage and crushing of tablets during dispensing.

“Through its unique working principle, the mini-tablet dispenser will be valuable in pediatrics, geriatrics and oncology where patients often require highly flexible oral dosing based on age, weight and other variables,” Phillips-Medisize president and CEO Matt Jennings said in a press release. “Furthermore, in smaller patient populations, the option to flexibly count to combine incremental mini-tablet doses offers an advantage over-preparing multiple fixed oral tablet dose strengths.”

Phillips-Medisize started industrialization preparations and plans to make the dispenser available globally in early 2020.

Filed Under: Drug-Device Combinations Tagged With: Phillips-Medisize

IN CASE YOU MISSED IT

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Study backs Tandem automated insulin delivery in pregnant women with type 1 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Abbott could pave new roads in diabetes management with dual sensor on the horizon

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS